Article Details
Retrieved on: 2021-08-18 13:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
WHO and Unitaid are concerned by Roche's statement yesterday, warning of a global shortage of tocilizumab (brand name Actemra/RoActemra), an IL6 inhibitor ...
Article found on: www.miragenews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here